Published in:
01-04-2008 | Original Article
A Mixed Method Study of the Merits of E-Prescribing Drug Alerts in Primary Care
Authors:
Kate L. Lapane, PhD, Molly E. Waring, MA PhD candidate, Karen L. Schneider, PhD, Catherine Dubé, EdD, Brian J. Quilliam, PhD
Published in:
Journal of General Internal Medicine
|
Issue 4/2008
Login to get access
Abstract
Objectives
The objective of this paper was to describe primary care prescribers’ perspectives on electronic prescribing drug alerts at the point of prescribing.
Design
We used a mixed-method study which included clinician surveys (web-based and paper) and focus groups with prescribers and staff.
Participants
Prescribers (n = 157) working in one of 64 practices using 1 of 6 e-prescribing technologies in 6 US states completed the quantitative survey and 276 prescribers and staff participated in focus groups.
Measurements
The study measures self-reported frequency of overriding of drug alerts; open-ended responses to: “What do you think of the drug alerts your software generates for you?”
Results
More than 40% of prescribers indicated they override drug–drug interactions most of the time or always (range by e-prescribing system, 25% to 50%). Participants indicated that the software and the interaction alerts were beneficial to patient safety and valued seeing drug–drug interactions for medications prescribed by others. However, they noted that alerts are too sensitive and often unnecessary. Participant suggestions included: (1) run drug alerts on an active medication list and (2) allow prescribers to set the threshold for severity of alerts.
Conclusions
Primary care prescribers recognize the patient safety value of drug prescribing alerts embedded within electronic prescribing software. Improvements to increase specificity and reduce alert overload are needed.